1. 1

    Do not conduct thrombophilia testing in adult patients under the age of 50 years ​unless the first episode of venous thromboembolism (VTE) occurs: in the absence of major transient risk factors (surgery, trauma, immobility); or in the absence of oestrogen-provocation; or at an unusual site

  2. 2

    Limit surveillance computed tomography (CT) scans in asymptomatic patients with confirmed complete remission following curative intent treatment for aggressive lymphoma – except for patients on a clinical trial  

  3. 3

    Do not extend anticoagulation beyond 3 months for a patient with a nonextensive, index venous thromboembolic event (VTE), which occurred in the setting of a major, transient risk factor

  4. 4

    Do not perform baseline or routine surveillance CT scans or bone marrow biopsy in patients with asymptomatic early stage chronic lymphocytic leukaemia (CLL)    

  5. 5

    Do not treat patients with immune thrombocytopenic purpura (ITP) unless platelet count <30,000/L , active bleeding or clinically significant risk of bleeding (including invasive procedures)